These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 24326321)

  • 41. Comparison of differing diagnostic criteria for diabetes: experience from a New Zealand community laboratory.
    Florkowski C; Thompson A
    N Z Med J; 1999 Sep; 112(1095):339-41. PubMed ID: 10553936
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Diabetes and impaired glucose tolerance prevalences in Turkish patients with impaired fasting glucose.
    Tutuncuoğlu P; Saraç F; Saygili F; Ozgen AG; Yilmaz C; Tüzün M
    Acta Diabetol; 2008 Sep; 45(3):151-6. PubMed ID: 18496644
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Relation of C-reactive protein to features of the metabolic syndrome in normal glucose tolerant, impaired glucose tolerant, and newly diagnosed type 2 diabetic subjects.
    Guerrero-Romero F; Rodríguez-Morán M
    Diabetes Metab; 2003 Feb; 29(1):65-71. PubMed ID: 12629450
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Plasma interleukin-6 levels are increased in subjects with impaired glucose tolerance but not in those with impaired fasting glucose in a cohort of Italian Caucasians.
    Cardellini M; Andreozzi F; Laratta E; Marini MA; Lauro R; Hribal ML; Perticone F; Sesti G
    Diabetes Metab Res Rev; 2007 Feb; 23(2):141-5. PubMed ID: 16952201
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Triglycerides and total cholesterol concentrations in association with IFG/IGT in Chinese adults in Qingdao, China.
    Cui J; Sun J; Wang W; Yasmeen N; Ke M; Xin H; Qiao Q; Ma A; Baloch Z
    BMC Public Health; 2018 Apr; 18(1):444. PubMed ID: 29615002
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Differences in insulin action and secretion, plasma lipids and blood pressure levels between impaired fasting glucose and impaired glucose tolerance in Japanese subjects.
    Miyazaki Y; Akasaka H; Ohnishi H; Saitoh S; DeFronzo RA; Shimamoto K
    Hypertens Res; 2008 Jul; 31(7):1357-63. PubMed ID: 18957806
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Rosiglitazone improves insulin sensitivity in nonobese subjects with impaired glucose tolerance: the role of adiponectin and C-reactive protein.
    Hung YJ; Lin SH; Pei D; Kuo SW; Hsieh CH; He CT; Hsing Lee C; Fan SC; Sheu WH
    Metabolism; 2006 Apr; 55(4):439-44. PubMed ID: 16546473
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Plasma glucose and prediction of microvascular disease and mortality: evaluation of 1997 American Diabetes Association and 1999 World Health Organization criteria for diagnosis of diabetes.
    Gabir MM; Hanson RL; Dabelea D; Imperatore G; Roumain J; Bennett PH; Knowler WC
    Diabetes Care; 2000 Aug; 23(8):1113-8. PubMed ID: 10937507
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Novel biomarkers of cardiometabolic risk are associated with plasma glucose within non-diabetic range. The Brazilian Longitudinal Study of Adult Health - ELSA-Brasil.
    Almeida-Pititto B; Ribeiro-Filho FF; Lotufo PA; Bensenor IM; Ferreira SR
    Diabetes Res Clin Pract; 2015 Jul; 109(1):110-6. PubMed ID: 25958099
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Metabolic characteristics of subjects with normal glucose tolerance and 1-h hyperglycaemia.
    Qian L; Fu X; Xu L; Zheng S; Zhou W; Wang X; Gu Y; Lin F; Luo M
    Clin Endocrinol (Oxf); 2008 Oct; 69(4):575-9. PubMed ID: 18248638
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Relationship between serum high-sensitivity C-reactive protein and obesity and impaired glycose metabolism in children and adolescents].
    Yang SP; Gong CX; Cao BY; Yan C
    Zhonghua Er Ke Za Zhi; 2006 Dec; 44(12):933-6. PubMed ID: 17254464
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Plasma Betatrophin Levels of Subjects Classified with Normal, Impaired, and Diabetic Glucose Tolerance, and Subjects with Impaired Fasting Glucose.
    Ozyazgan S; Onal B; Kurtulus EM; Uzun H; Akkan G; Konukoglu D
    Horm Metab Res; 2017 Jun; 49(6):434-439. PubMed ID: 28351091
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prediabetes is associated with lower brain gray matter volume in the general population. The Study of Health in Pomerania (SHIP).
    Markus MRP; Ittermann T; Wittfeld K; Schipf S; Siewert-Markus U; Bahls M; Bülow R; Werner N; Janowitz D; Baumeister SE; Felix SB; Dörr M; Rathmann W; Völzke H; Grabe HJ
    Nutr Metab Cardiovasc Dis; 2017 Dec; 27(12):1114-1122. PubMed ID: 29162362
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evaluation of insulin release and insulin sensitivity through oral glucose tolerance test: differences between NGT, IFG, IGT, and type 2 diabetes mellitus. A cross-sectional and follow-up study.
    Pontiroli AE; Pizzocri P; Caumo A; Perseghin G; Luzi L
    Acta Diabetol; 2004 Jun; 41(2):70-6. PubMed ID: 15224208
    [TBL] [Abstract][Full Text] [Related]  

  • 55. 1 h Postload Glycemia Is Associated with Low Endogenous Secretory Receptor for Advanced Glycation End Product Levels and Early Markers of Cardiovascular Disease.
    Di Pino A; Urbano F; Scicali R; Di Mauro S; Filippello A; Scamporrino A; Piro S; Purrello F; Rabuazzo AM
    Cells; 2019 Aug; 8(8):. PubMed ID: 31426413
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Association between C-reactive protein and pre-diabetic status in a Chinese Han clinical population.
    Lin J; Zhang M; Song F; Qin J; Wang R; Yao P; Ying C; Hu FB; Liu L
    Diabetes Metab Res Rev; 2009 Mar; 25(3):219-23. PubMed ID: 19116941
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prevalence of glucose abnormalities and diagnostic value of fasting glucose and fasting insulin in urban Hispanics.
    Hoffmann IS; Alfieri AB; Cubeddu LX
    Am J Ther; 2013; 20(4):369-75. PubMed ID: 23528370
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Increased arterial stiffness in healthy subjects with high-normal glucose levels and in subjects with pre-diabetes.
    Shin JY; Lee HR; Lee DC
    Cardiovasc Diabetol; 2011 Apr; 10():30. PubMed ID: 21492487
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Metabolic and cardiovascular risk factors in subjects with impaired fasting glucose: the 100 versus 110 mg/dL threshold.
    Andreozzi F; Succurro E; Mancuso MR; Perticone M; Sciacqua A; Perticone F; Sesti G
    Diabetes Metab Res Rev; 2007 Oct; 23(7):547-50. PubMed ID: 17311284
    [TBL] [Abstract][Full Text] [Related]  

  • 60. C-reactive protein and gestational diabetes: the central role of maternal obesity.
    Retnakaran R; Hanley AJ; Raif N; Connelly PW; Sermer M; Zinman B
    J Clin Endocrinol Metab; 2003 Aug; 88(8):3507-12. PubMed ID: 12915627
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.